South Carolina Clinics See Patient Flood as Medicare Expands GLP-1 Weight Loss Drug Coverage

Medicare's recent expansion of coverage for GLP-1 weight loss drugs has triggered a surge in patients seeking treatment at South Carolina clinics. The coverage change, part of CMS's pilot program, is driving significant new volume as eligible beneficiaries seek prescriptions for drugs like Wegovy and Zepbound. This operational influx for clinics includes increased demands for patient education, prior authorization workflows, and medication management. The pilot's early enrollment data will shape future coverage decisions for millions of Medicare beneficiaries. For practices with a high Medicare population, expect continued high patient interest and prepare staff for counseling on eligibility criteria and coverage limitations under the pilot.